Publications by authors named "Marion Frew"

Claim this Profile
R
RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.
David T Bowen, Marion E Frew, Robert Hills, Rosemary E Gale, Keith Wheatley

Blood· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16).
Peter J M Valk, David T Bowen, Marion E Frew, Anne C Goodeve, Bob Löwenberg

Haematologica· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antioxidant enzyme expression in myelodysplastic and acute myeloid leukemia bone marrow: further evidence of a pathogenetic role for oxidative stress?
David Bowen, Lihui Wang, Marion Frew, Ron Kerr, Mike Groves

Haematologica· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication.
David T Bowen, Marion E Frew, Sara Rollinson, Philippa L Roddam, Ann Dring

Blood· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors.
Panagiotis D Kottaridis, Rosemary E Gale, Stephen E Langabeer, Marion E Frew, David T Bowen

Blood· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis